Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF (MSP-INVO IVF)
A Scientific & Clinical Review of Minimal Stimulation Protocol Using AROMEK (Letrozole) and Follitrope (Recombinant FSH)Combined With INVOCell(Intravaginal Culturing) - Effectiveness as Low Cost IVF
Sponsor: Galaxy Pharma (Pvt) Limited
Listed as NCT01058252, this observational or N/A phase trial focuses on Low Responders and Mild to Moderate Male Factor Infertility and remains ongoing. Sponsored by Galaxy Pharma (Pvt) Limited, it has been updated 8 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Apr 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Apr 2021 — Apr 2023 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Galaxy Pharma (Pvt) Limited
- Ova IVF & Reproductive Health Clinics, Karachi
For direct contact, visit the study record on ClinicalTrials.gov .